Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11720906 | 0.89 | — | — | |
| SCHEMBL314258 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL7690455 | 0.80 | — | — | |
| Zinc Ion SCHEMBL8164666 | 0.80 | CA1 (0.50) | — | |
| SCHEMBL5152734 | 0.67 | CA1 (0.60) | — | |
| SCHEMBL147247 | 0.67 | — | — | |
| Potassium Ion SCHEMBL1284 | 0.67 | — | — | |
| SCHEMBL352283 | 0.67 | — | — | |
| SCHEMBL10920727 | 0.67 | — | — | |
| SCHEMBL3799398 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1689348-B1 | Oligosaccharide compositions and use thereof in the treatment of infection | CHILDRENS HOSP MEDICAL CENTER (US) | 2013-05-15 | — | — | EP | disclosed |
| EP-2497478-A2 | Oligosaccaride compositions and use thereof in the treatment of infection | Children's Hospital Medical Center (US) | 2012-09-12 | — | — | EP | disclosed |
| US-20110207659-A1 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2011-08-25 | — | — | US | disclosed |
| EP-1689348-A4 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | CHILDRENS HOSP MEDICAL CENTER (US) | 2008-11-26 | — | — | EP | disclosed |
| EP-1689348-A2 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | Cincinnati Childrens's Hospital Medical Center (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005055944-A9 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | CHILDRENS HOSP MEDICAL CENTER (US) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005055944-A2 | OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2005-06-23 | — | — | WO | disclosed |